Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
EN3835 for Cellulite
NCT03329989Phase 2Completed
- Sponsor
- Endo International plc
- Start
- Nov 2017
- Primary completion
- Sep 2018
- Modality
- Therapeutic Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of collagenase clostridium histolyticum in cellulite, sponsored by Endo International plc. Started Nov 2017; status: completed.
02
Drugs
collagenase clostridium histolyticum
03
Conditions
cellulite
Beyond the preview
Go deeper on NCT03329989.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03329989.